These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1761452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections.
    Kammer RB, Ress R.
    Diagn Microbiol Infect Dis; 1991; 14(1):101-5. PubMed ID: 2013204
    [Abstract] [Full Text] [Related]

  • 3. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A, Jungwirth R.
    Infection; 1991; 19(5):353-62. PubMed ID: 1800377
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis.
    McCabe R, Rumans L, Perrotta R, Mogabgab W.
    J Chemother; 1993 Apr; 5(2):124-32. PubMed ID: 8515295
    [Abstract] [Full Text] [Related]

  • 5. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Apr; 14(1):63-74. PubMed ID: 2013211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.
    Jones RN.
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S77-83. PubMed ID: 7567314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Ruoff GE.
    Clin Ther; 1992 Jul; 14(1):41-53. PubMed ID: 1576625
    [Abstract] [Full Text] [Related]

  • 16. Antibacterial activity of ceftibuten, a new oral third generation cephalosporin.
    Debbia EA, Schito GC, Pesce A.
    J Chemother; 1991 Aug; 3(4):209-25. PubMed ID: 1779255
    [Abstract] [Full Text] [Related]

  • 17. Comparison of ceftibuten versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
    Aubier MA.
    Chemotherapy; 1997 Aug; 43(4):297-302. PubMed ID: 9209787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    Diagn Microbiol Infect Dis; 1991 Aug; 14(1):45-52. PubMed ID: 2013210
    [Abstract] [Full Text] [Related]

  • 20. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Wiseman LR, Balfour JA.
    Drugs; 1994 May; 47(5):784-808. PubMed ID: 7520858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.